Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 1 2Phase 2/3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 523Leukemia, Myeloid, Acute 499Neoplasms 381Carcinoma, Non-Small-Cell Lung 381Pancreatic Neoplasms 329Precursor Cell Lymphoblastic Leukemia-Lymphoma 319Multiple Myeloma 312Glioblastoma 311Melanoma 310Prostatic Neoplasms 293Leukemia 289Neoplasm Metastasis 284Brain Neoplasms 277Lymphoma 271Lung Neoplasms 270Recurrence 267Ovarian Neoplasms 247Colorectal Neoplasms 246Lymphoma, Non-Hodgkin 242Leukemia, Lymphocytic, Chronic, B-Cell 231Glioma 209Myelodysplastic Syndromes 208Lymphoma, Large B-Cell, Diffuse 186Carcinoma, Hepatocellular 173Lymphoma, Follicular 167Head and Neck Neoplasms 162Hodgkin Disease 160Lymphoma, Mantle-Cell 155Burkitt Lymphoma 154Sarcoma 150

Interventions

Topotecan 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Meningitis × Clear all
NCT00074607 2012-11-12

Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine

Baylor College of Medicine

Phase 1 Terminated
10 enrolled
CNS

Meningitis, Neoplasms, Meningeal Carcinomatosis

NCT00674674 2012-05-15

PBTC-019

Baylor College of Medicine

Phase 1 Completed
22 enrolled
CNS

Meningitis, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡